We are live on ! Find out more
CAM

ClariVest Asset Management Portfolio holdings

AUM $980M
1-Year Est. Return 60.89%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$2.08B
AUM Growth
-$217M
Cap. Flow
-$153M
Cap. Flow %
-7.37%
Top 10 Hldgs %
34.64%
Holding
779
New
87
Increased
56
Reduced
307
Closed
90

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$21.3M
2
PYPL icon
PayPal
PYPL
+$14.2M
3
FISV
Fiserv Inc
FISV
+$13.3M
4
ENPH icon
Enphase Energy
ENPH
+$11.3M
5
INTU icon
Intuit
INTU
+$9.13M

Sector Composition

Rank Sector Weight
1 Technology 37.12%
2 Healthcare 15.2%
3 Consumer Discretionary 12.14%
4 Financials 7.92%
5 Industrials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STEM icon
376
Stem
STEM
$52.7M
$439K 0.02%
+1,645
New +$421K
MQ icon
377
Marqeta
MQ
$1.66B
$433K 0.02%
+15,203
New +$506K
CIVI
378
DELISTED
Civitas Resources
CIVI
$431K 0.02%
7,513
-43,659
-85% -$2.57M
RCKT icon
379
Rocket Pharmaceuticals
RCKT
$394M
$431K 0.02%
+27,000
New +$421K
VNDA icon
380
Vanda Pharmaceuticals
VNDA
$302M
$427K 0.02%
43,200
+13,800
+47% +$146K
VALE icon
381
Vale
VALE
$62.6B
$426K 0.02%
32,000
-20,600
-39% -$271K
IRMD icon
382
iRadimed
IRMD
$1.18B
$422K 0.02%
14,022
INFY icon
383
Infosys
INFY
$50.7B
$416K 0.02%
24,500
-21,000
-46% -$392K
KZR
384
DELISTED
Kezar Life Sciences
KZR
$416K 0.02%
4,840
RYTM icon
385
Rhythm Pharmaceuticals
RYTM
$7.96B
$412K 0.02%
+16,800
New +$312K
VSEC icon
386
VSE Corp
VSEC
$6.12B
$411K 0.02%
11,611
STKS icon
387
The ONE Group
STKS
$53M
$409K 0.02%
61,573
+17,400
+39% +$134K
ASAN icon
388
Asana
ASAN
$2.13B
$405K 0.02%
18,213
+5,209
+40% +$112K
RGNX icon
389
Regenxbio
RGNX
$708M
$400K 0.02%
15,126
-42
-0.3% -$1.25K
PWSC
390
DELISTED
PowerSchool Holdings, Inc.
PWSC
$396K 0.02%
+23,687
New +$383K
PAHC icon
391
Phibro Animal Health
PAHC
$1.39B
$392K 0.02%
29,500
-42
-0.1% -$725
HSII
392
DELISTED
Heidrick & Struggles
HSII
$383K 0.02%
14,730
GERN icon
393
Geron
GERN
$949M
$364K 0.02%
+155,496
New +$348K
PDD icon
394
Pinduoduo
PDD
$131B
$363K 0.02%
5,800
+3,800
+190% +$221K
ITOS
395
DELISTED
iTeos Therapeutics
ITOS
$362K 0.02%
19,000
OIS icon
396
Oil States International
OIS
$491M
$355K 0.02%
91,327
APPN icon
397
Appian
APPN
$2.48B
$352K 0.02%
8,598
-24
-0.3% -$1.16K
EDIT icon
398
Editas Medicine
EDIT
$442M
$348K 0.02%
28,417
-78
-0.3% -$1.22K
ARRY icon
399
Array Technologies
ARRY
$855M
$342K 0.02%
+20,695
New +$358K
HBIO icon
400
Harvard Bioscience
HBIO
$29.2M
$341K 0.02%
13,320
+2,610
+24% +$86.3K

Similar funds

ClariVest Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, ClariVest Asset Management held 779 positions worth $2.08B, down 9.5% from $2.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

ClariVest Asset Management withdrew a net $153M in Q3 2022, closing 90 positions and reducing 307 holdings. Its most notable exit was Adobe, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, ClariVest Asset Management opened a new position in Centene worth $18.6M.

  • ClariVest Asset Management's largest Q3 2022 buy was Centene: 238,714 shares worth $18.6M.
  • ClariVest Asset Management added most to Enphase Energy in Q3 2022, an estimated $11.3M increase.
  • ClariVest Asset Management's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $15.4M.
  • ClariVest Asset Management fully exited Adobe in Q3 2022, selling an estimated $19.5M.
  • ClariVest Asset Management's ten largest holdings make up 35% of its $2.08B portfolio in Q3 2022.
  • ClariVest Asset Management opened 87 new positions and closed 90 in Q3 2022.
  • ClariVest Asset Management's portfolio value fell 9.5% quarter-over-quarter to $2.08B.

Based on ClariVest Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.